日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Multi-omics analysis the effects of Dhx37 deficiency on testis development and nucleolar homeostasis

多组学分析Dhx37缺陷对睾丸发育和核仁稳态的影响

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02875-1
Jiang, Yuqing; Chen, Jiali; Ren, Yanshuang; Peng, Wenyuan; Shen, Wanjun; Zhang, Yingyu; Liu, Jie; Fu, Liujun; Li, Liping; Ma, Yujin; Jiang, Hongwei; Peng, Huifang
发育与干细胞
发表日期：2026
文献求助 收藏

Unveiling the immune microenvironment in diabetic nephropathy: from mechanisms to therapeutics

揭示糖尿病肾病中的免疫微环境：从机制到治疗

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1750484
Jiang, Tao; Chen, Ran; Chang, Jianying; Duan, Jiajia; Wang, Yanqiu; Sun, Yuhan; Chen, Xiaowan; Ma, Yujin; Zhang, Liwen; Jiang, Hongwei; Chen, Hetao
代谢
糖尿病
糖尿病肾病
免疫/内分泌
发表日期：2026
文献求助 收藏

Metabolomics identifies chenodeoxycholic acid as a protective factor in diabetic foot ulcers

代谢组学研究发现鹅去氧胆酸是糖尿病足溃疡的保护因素

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2026.1754743
Li, Ying; Guo, Ran; Lv, Lu; Jiang, Tao; Zhang, Chenning; Chang, Jiangying; Hu, KeYan; Peng, Huifang; Chen, Lulu; Chen, Ran; Chen, Hetao; Ma, Yujin
糖尿病
代谢
发表日期：2026
文献求助 收藏

Efficacy and safety of narlumosbart, an anti-RANKL monoclonal antibody, in postmenopausal women with osteoporosis: a multi-center, randomized, double-blind, placebo- and active-controlled, phased II study

narlumosbart（一种抗RANKL单克隆抗体）治疗绝经后骨质疏松症女性的疗效和安全性：一项多中心、随机、双盲、安慰剂和活性药物对照的II期研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103329
Chi, Yue; Li, Yukun; Cheng, Qun; Cai, Hanqing; Zeng, Yuhong; Sheng, Hui; Song, Bing; Li, Hongmei; Shen, Lin; Li, Min; Xing, Ying; Cheng, Mei; Ma, Yujin; Wang, Difei; Zhu, Mei; Lu, Weiping; Yan, Shuang; Zhang, Xueyuan; Yuan, Jing; Yang, Baofang; Li, Jun; Wang, Juan; Wu, Zhufeng; Xia, Weibo
单克隆抗体
代谢
RAN
骨质疏松
发表日期：2025
文献求助 收藏

Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial

小檗碱熊去氧胆酸盐治疗2型糖尿病：一项随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2024.62185
Ji, Linong; Ma, Jianhua; Ma, Yujin; Cheng, Zhifeng; Gan, Shenglian; Yuan, Guoyue; Liu, Dexue; Li, Sheli; Liu, Yu; Xue, Xia; Bai, Jie; Wang, Kun; Cai, Hanqing; Li, Shu; Liu, Kui; Yu, Meng; Liu, Liping
糖尿病
代谢
发表日期：2025
文献求助 收藏

Exploring the glucose-lowering and anti-inflammatory immune mechanism of artemether by AMPK/mTOR pathway and microbiome based on multi-omics.

基于多组学方法，探索蒿甲醚通过 AMPK/mTOR 通路和微生物组发挥降血糖和抗炎免疫作用的机制

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1520439
Jiang Tao, Du Peipei, Liu Dongxia, Chen Hetao, Ma Yujin, Hu Bin, Li Jingna, Jiang Hongwei, Li Xuejiao
微生物学
AMPK
mTOR
发表日期：2025
文献求助 收藏

Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia

病例报告：剂量递增的马杜肽（一种 GLP-1/GCGR 双重激动剂）在一名患有肥胖、2 型糖尿病和高尿酸血症的青少年中的疗效和安全性

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1654506
Cheng, Wenfei; Chen, Zilong; Li, Puyu; Zhang, Yingyu; Ma, Yujin; Liu, Peng; Jiang, Hongwei
糖尿病
肥胖
GLP-1
代谢
发表日期：2025
文献求助 收藏

Early diagnosis and risk factors of diabetic peripheral neuropathy in type 1 diabetes: insights from current perception threshold testing

1型糖尿病糖尿病周围神经病变的早期诊断和危险因素：来自当前感知阈值测试的启示

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1496635
Zhao, Qian; Wang, Jialin; Liu, Fangfang; Jiang, Hongwei; Ma, Yujin
糖尿病
代谢
发表日期：2025
文献求助 收藏

Profile of DHX37 gene defects in human genetic diseases: 46,XY disorders of sex development

DHX37基因缺陷在人类遗传疾病中的分布：46,XY性发育异常

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1507749
Peng, Huifang; Peng, Wenyuan; Chen, Jiali; Hu, Keyan; Zhang, Yingyu; Ma, Yujin; Jiang, Hongwei
发育与干细胞
发表日期：2025
文献求助 收藏

A systematic review and evidence assessment of monogenic gene-disease relationships in human male infertility

对人类男性不育症中单基因与疾病关系的系统性综述和证据评估

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1643543
Zhao, Qian; Peng, Huifang; Chen, Jiali; Zhang, Hui; Ma, Yujin; Jiang, Hongwei
发表日期：2025
文献求助 收藏